rank	phenotype	cui	assoc in neigh	assoc in intom	probability	Benjamini-Hochberg	genes	
28	Hyperammonemia	C0220994	2	39	8.531891022567351e-07	4.84429065744e-05	CAD,SLC25A13
45	Neurologic, endocrine, and pancreatic disease, multisystem, infantile-onset	C0030286	2	57	2.7178500348057355e-06	7.78546712803e-05	ALB,SLC25A13
52	Abnormality of nitrogen compound homeostasis	C4025336	2	74	5.992560890955012e-06	8.99653979239e-05	CAD,SLC25A13
53	Azotemia	C0242528	2	75	6.2404937687388085e-06	9.16955017301e-05	CAD,SLC25A13
57	Hyperlipidemia, combined, 1	C0020473	3	293	9.809816641781488e-06	9.8615916955e-05	ALB,CAD,SLC25A13
96	Abnormality of sulfur amino acid metabolism	C4021660	1	25	6.774529818465158e-05	0.000166089965398	SLC25A13
97	Malignant neoplasm of adrenal cortex	C0346402	1	26	7.337046293298677e-05	0.000167820069204	ALB
98	Abnormality of lipid metabolism	C4025650	2	172	7.494775055949532e-05	0.00016955017301	ALB,SLC25A13
99	Esophageal varix	C0014867	1	27	7.921821348377822e-05	0.000171280276817	ALB
100	Urolithiasis	C0451641	1	27	7.921821348377822e-05	0.000173010380623	ALB
101	Echinococcosis	C0013502	1	28	8.528827337472844e-05	0.000174740484429	ALB
102	Epidermolysis bullosa simplex, Cockayne-Touraine type	C0079298	1	28	8.528827337472844e-05	0.000176470588235	KRT9
103	Palmar hyperkeratosis	C0240641	1	28	8.528827337472844e-05	0.000178200692042	KRT9
104	Broad-based gait	C0856863	1	28	8.528827337472844e-05	0.000179930795848	CAD
105	Familial hypercholesterolemia	C0020445	2	182	8.863144957182989e-05	0.000181660899654	ALB,CAD
106	Proliferative retinopathy	C0339467	1	29	9.158060090785902e-05	0.00018339100346	ALB
107	Verrucae	C0043037	1	30	9.80949782208862e-05	0.000185121107266	KRT9
108	Isolated somatotropin deficiency	C3714796	1	30	9.80949782208862e-05	0.000186851211073	ALB
109	Renal tubular acidosis, distal, autosomal dominant	C0001126	1	31	0.0001048310758585691	0.000188581314879	CAD
110	Substance Use Disorders	C0038586	1	31	0.0001048310758585691	0.000190311418685	ALB
111	Poikilocytosis	C0221281	1	31	0.0001048310758585691	0.000192041522491	CAD
112	Dentatorubral pallidoluysian atrophy	C0751781	1	31	0.0001048310758585691	0.000193771626298	ALB
113	Brain Diseases	C0006111	2	194	0.00010709318062862572	0.000195501730104	ALB,SLC1A1
114	Angiokeratoma	C0002985	1	32	0.00011178890543117603	0.00019723183391	ALB
115	Isolated growth hormone deficiency type 1B	C0013338	1	32	0.00011178890543117603	0.000198961937716	ALB
116	Plantar hyperkeratosis	C1856954	1	32	0.00011178890543117603	0.000200692041522	KRT9
117	Abnormality of the level of lipoprotein cholesterol	C4023615	1	33	0.000118968167405753	0.000202422145329	SLC25A13
118	Familial type 3 hyperlipoproteinemia	C0020479	1	34	0.00012636875968519146	0.000204152249135	CAD
119	Pericardial effusion	C0031039	1	34	0.00012636875968519146	0.000205882352941	ALB
120	Mumps	C0026780	1	35	0.00013399040894623848	0.000207612456747	ALB
121	Rhinitis, Allergic, Perennial	C0035457	1	35	0.00013399040894623848	0.000209342560554	ALB
122	Endemic Cretinism	C0342200	1	35	0.00013399040894623848	0.00021107266436	ALB
123	Prominent nose	C0426415	1	35	0.00013399040894623848	0.000212802768166	ASPH
124	Hypercholesterolemia, autosomal dominant, type B	C0020443	2	212	0.00013923328031706372	0.000214532871972	ALB,SLC25A13
125	Hemangioblastoma	C0206734	1	36	0.00014183295795555662	0.000216262975779	ALB
126	Ectopia lentis, isolated autosomal recessive	C0013581	1	38	0.00015818006238710325	0.000217993079585	ASPH
127	Mesangiocapillary glomerulonephritis, type II	C0017662	1	38	0.00015818006238710325	0.000219723183391	ALB
128	Nephrosclerosis	C0027719	1	38	0.00015818006238710325	0.000221453287197	ALB
129	Peripheral motor neuropathy	C0235025	1	38	0.00015818006238710325	0.000223183391003	ALB
130	End Stage Liver Disease	C0745744	1	38	0.00015818006238710325	0.00022491349481	ALB
131	Coronary Thrombosis	C0010072	1	39	0.00016668421761822927	0.000226643598616	CAD
132	Abnormal albumin level	C4023036	1	39	0.00016668421761822927	0.000228373702422	ALB
133	Hereditary spherocytosis	C0037889	1	40	0.00017540852516817473	0.000230103806228	CAD
134	Bronchogenic Carcinoma	C0007121	1	41	0.00018435285628271014	0.000231833910035	ALB
135	Confusion	C0009676	1	41	0.00018435285628271014	0.000233564013841	SLC25A13
136	CADASIL	C0751587	1	41	0.00018435285628271014	0.000235294117647	ASPH
137	Neuroblastic tumors	C1334953	1	42	0.00019351691005320415	0.000237024221453	ASPH
138	Coronary artery aneurysm	C0010051	1	43	0.0002029006167963976	0.00023875432526	ALB
139	Hyperlipoproteinemia	C0020476	1	43	0.0002029006167963976	0.000240484429066	ALB
140	Hyperlipoproteinemia Type IIa	C0745103	1	43	0.0002029006167963976	0.000242214532872	ALB
141	Tubulointerstitial nephritis	C0027707	1	44	0.0002125037576897748	0.000243944636678	ALB
142	Single tumor	C1298180	1	44	0.0002125037576897748	0.000245674740484	ALB
143	Nephrotic Syndrome, Minimal Change	C1704321	1	44	0.0002125037576897748	0.000247404844291	ALB
144	Skin Diseases, Genetic	C0037277	1	46	0.00023236760995670735	0.000249134948097	KRT9
145	Isochromosomes	C0242621	1	47	0.00024262789107021288	0.000250865051903	CAD
146	Varicella zoster	C0740380	1	47	0.00024262789107021288	0.000252595155709	ALB
147	Drusen	C1260959	1	47	0.00024262789107021288	0.000254325259516	ALB
148	Neoplasm of the liver	C0023903	4	1290	0.00025157662429675653	0.000256055363322	ACY3,ALB,CAD,SLC25A13
149	Increased antibody level in blood	C0151669	1	48	0.00025310692253288636	0.000257785467128	KRT9
150	Bile duct cancer resectable	C0740277	1	48	0.00025310692253288636	0.000259515570934	ASPH
151	Insulin resistance syndrome	C3714619	1	48	0.00025310692253288636	0.00026124567474	ALB
